5α-reductase

5α-Reductase (5-alpha-reductase) is an enzyme that plays a significant role in the metabolism of hormones. It converts testosterone, the male sex hormone, into dihydrotestosterone (DHT), a more potent androgen. This enzyme is crucial in the development of male genitalia during embryonic development and in the regulation of hair growth, prostate enlargement, and sebaceous gland activity in adults. There are three known isoforms of 5α-reductase, each encoded by a separate gene and having distinct tissue distributions and enzymatic activities.

Function

5α-Reductase catalyzes the reduction of the double bond of testosterone, producing dihydrotestosterone (DHT) in peripheral tissues. DHT is an essential androgen that exerts stronger effects than testosterone on the target tissues. The enzyme's activity is critical in the prostate gland, skin, hair follicles, and liver, influencing various physiological and pathological processes.

Isoforms

There are three isoforms of the 5α-reductase enzyme, identified as Type 1, Type 2, and Type 3, each with a unique tissue distribution and specific role in the body:

• Type 1 is predominantly found in the sebaceous glands of the skin, liver, and brain, playing a role in postnatal development.
• Type 2 is mainly located in the genital tissues, including the prostate, seminal vesicles, and hair follicles, and is crucial for male sexual development.
• Type 3 has been identified more recently and is less understood, but is thought to contribute to the overall activity of the enzyme in the body.

Clinical Significance

The activity of 5α-reductase has implications in several medical conditions:

• Benign Prostatic Hyperplasia (BPH): Increased activity of 5α-reductase in the prostate contributes to the enlargement of the prostate gland, a common condition in older men.
• Androgenetic Alopecia (Male Pattern Baldness): The conversion of testosterone to DHT in hair follicles is a key factor in the development of male pattern baldness.
• Hirsutism: Excessive hair growth in women, often due to increased levels of androgens, including DHT.
• 5α-Reductase Deficiency: A rare genetic condition where the enzyme is inactive, leading to underdeveloped male genitalia at birth and a female external genitalia appearance, despite having a male genetic makeup.

Treatment

Inhibitors of 5α-reductase, such as finasteride and dutasteride, are used to treat conditions like benign prostatic hyperplasia and androgenetic alopecia by reducing the production of DHT. These medications can significantly alleviate symptoms but may also have side effects, including sexual dysfunction and depression.

Research Directions

Research continues to explore the role of 5α-reductase in health and disease, including its potential involvement in cancer, particularly prostate cancer, and its role in the central nervous system. Understanding the enzyme's function and regulation could lead to new therapeutic strategies for treating related conditions.

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian